Clinical trial
Prostacyclin (PGI2) Pathway to Enhance Wound Healing in Diabetic Foot Ulcers
NCT05099367 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prostacyclin (PGI2) Pathway to Enhance Wound Healing in Diabetic Foot Ulcers
- Lead sponsor
- University Hospital, Grenoble
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 1, 2021
- Completion date
- August 31, 2025
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.